Cargando…

Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia

SUMMARY: A 33-year-old gentleman of Egyptian heritage presented with a 21 years history of unexplained and recurrent hypercalcaemia, nephrolithiasis, nephrocalcinosis, and myocarditis. A similar history was also found in two first-degree relatives. Further investigation into the vitamin D metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Nizar, Ryizan, Cantley, Nathan W P, Tang, Jonathan C Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495722/
https://www.ncbi.nlm.nih.gov/pubmed/34551392
http://dx.doi.org/10.1530/EDM-21-0058
_version_ 1784579607477878784
author Nizar, Ryizan
Cantley, Nathan W P
Tang, Jonathan C Y
author_facet Nizar, Ryizan
Cantley, Nathan W P
Tang, Jonathan C Y
author_sort Nizar, Ryizan
collection PubMed
description SUMMARY: A 33-year-old gentleman of Egyptian heritage presented with a 21 years history of unexplained and recurrent hypercalcaemia, nephrolithiasis, nephrocalcinosis, and myocarditis. A similar history was also found in two first-degree relatives. Further investigation into the vitamin D metabolism pathway identified the biochemical hallmarks of infantile hypercalcaemia type 1 (IIH). A homozygous, likely pathogenic, variant in CYP24A1 was found on molecular genetic analysis confirming the diagnosis. Management now focuses on removing excess vitamin D from the metabolic pathway as well as reducing calcium intake to achieve serum-adjusted calcium to the middle of the reference range. If undiagnosed, IIH can cause serious renal complications and metabolic bone disease. LEARNING POINTS: Infantile hypercalcaemia type 1 (IIH) is an autosomal recessive disorder characterised by homozygous mutations in the CYP24A1 gene that encodes the 24-hydroxylase enzyme used to convert active vitamin D metabolites such as 1,25-(OH)(2)-vitamin D into their inactive form. IIH should be questioned in individuals presenting with a history of unexplained hypercalcaemia, especially if presenting from childhood and/or where there is an accompanying family history of the same in first and/or second degree relatives, causing complications such as nephrocalcinosis, pericarditis, and calcium-based nephrolithiasis. Associated biochemistry of IIH is persistent mild to moderate hypercalcaemia, normal or raised 25-(OH)-vitamin D and elevated 1,25-(OH)(2)-vitamin D. An elevated ratio of 25-(OH)-vitamin D to 24,25-(OH)(2)-vitamin D can be a useful marker of defects in the 24-hydroxylase enzyme, whose measurement can be facilitated through the supra-regional assay service. Management should focus on limiting the amount of vitamin D introduced into the body either via sunlight exposure or supplementation in addition to calcium dietary restriction to try and maintain appropriate calcium homeostasis.
format Online
Article
Text
id pubmed-8495722
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-84957222021-10-12 Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia Nizar, Ryizan Cantley, Nathan W P Tang, Jonathan C Y Endocrinol Diabetes Metab Case Rep Unique/Unexpected Symptoms or Presentations of a Disease SUMMARY: A 33-year-old gentleman of Egyptian heritage presented with a 21 years history of unexplained and recurrent hypercalcaemia, nephrolithiasis, nephrocalcinosis, and myocarditis. A similar history was also found in two first-degree relatives. Further investigation into the vitamin D metabolism pathway identified the biochemical hallmarks of infantile hypercalcaemia type 1 (IIH). A homozygous, likely pathogenic, variant in CYP24A1 was found on molecular genetic analysis confirming the diagnosis. Management now focuses on removing excess vitamin D from the metabolic pathway as well as reducing calcium intake to achieve serum-adjusted calcium to the middle of the reference range. If undiagnosed, IIH can cause serious renal complications and metabolic bone disease. LEARNING POINTS: Infantile hypercalcaemia type 1 (IIH) is an autosomal recessive disorder characterised by homozygous mutations in the CYP24A1 gene that encodes the 24-hydroxylase enzyme used to convert active vitamin D metabolites such as 1,25-(OH)(2)-vitamin D into their inactive form. IIH should be questioned in individuals presenting with a history of unexplained hypercalcaemia, especially if presenting from childhood and/or where there is an accompanying family history of the same in first and/or second degree relatives, causing complications such as nephrocalcinosis, pericarditis, and calcium-based nephrolithiasis. Associated biochemistry of IIH is persistent mild to moderate hypercalcaemia, normal or raised 25-(OH)-vitamin D and elevated 1,25-(OH)(2)-vitamin D. An elevated ratio of 25-(OH)-vitamin D to 24,25-(OH)(2)-vitamin D can be a useful marker of defects in the 24-hydroxylase enzyme, whose measurement can be facilitated through the supra-regional assay service. Management should focus on limiting the amount of vitamin D introduced into the body either via sunlight exposure or supplementation in addition to calcium dietary restriction to try and maintain appropriate calcium homeostasis. Bioscientifica Ltd 2021-08-23 /pmc/articles/PMC8495722/ /pubmed/34551392 http://dx.doi.org/10.1530/EDM-21-0058 Text en © The authors https://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Unique/Unexpected Symptoms or Presentations of a Disease
Nizar, Ryizan
Cantley, Nathan W P
Tang, Jonathan C Y
Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia
title Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia
title_full Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia
title_fullStr Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia
title_full_unstemmed Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia
title_short Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia
title_sort infantile hypercalcaemia type 1: a vitamin d-mediated, under-recognised cause of hypercalcaemia
topic Unique/Unexpected Symptoms or Presentations of a Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495722/
https://www.ncbi.nlm.nih.gov/pubmed/34551392
http://dx.doi.org/10.1530/EDM-21-0058
work_keys_str_mv AT nizarryizan infantilehypercalcaemiatype1avitamindmediatedunderrecognisedcauseofhypercalcaemia
AT cantleynathanwp infantilehypercalcaemiatype1avitamindmediatedunderrecognisedcauseofhypercalcaemia
AT tangjonathancy infantilehypercalcaemiatype1avitamindmediatedunderrecognisedcauseofhypercalcaemia